Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
tegaserod 5-hydroxytryptamine receptor 2a small molecule NA drugbank Irritable Bowel Syndrome[MeSHID:D043183]
Constipation[MeSHID:D003248]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]		 NA approved,investigational,withdrawn antagonist
tegaserod 5-hydroxytryptamine receptor 2b small molecule NA drugbank , DGIDB Irritable Bowel Syndrome[MeSHID:D043183]
Constipation[MeSHID:D003248]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]		 1.25 approved,investigational,withdrawn antagonist
tegaserod 5-hydroxytryptamine receptor 2c small molecule NA drugbank Irritable Bowel Syndrome[MeSHID:D043183]
Constipation[MeSHID:D003248]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]		 NA approved,investigational,withdrawn antagonist
tegaserod 5-ht 4 receptor NA Successful target TTD , DGIDB Irritable Bowel Syndrome[MeSHID:D043183]
Constipation[MeSHID:D003248]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]		 5.48 approved unknown
tegaserod 5-hydroxytryptamine receptor 4 small molecule NA drugbank , DGIDB Irritable Bowel Syndrome[MeSHID:D043183]
Constipation[MeSHID:D003248]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]		 5.48 approved,investigational,withdrawn antagonist,partial agonist
tegaserod 5-hydroxytryptamine receptor 4 small molecule NA drugbank , DGIDB Irritable Bowel Syndrome[MeSHID:D043183]
Constipation[MeSHID:D003248]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]		 5.48 approved,investigational,withdrawn antagonist,partial agonist,agonist
tegaserod 5-ht 4 receptor NA Successful target TTD , DGIDB Irritable Bowel Syndrome[MeSHID:D043183]
Constipation[MeSHID:D003248]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]		 5.48 approved agonist
click here to return to the previous page